At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DRUG Bright Minds Biosciences Inc
Trading 05-15 13:49:16 EDT
1.12
+0.07
+6.66%
High1.12Low1.01Vol23.09K
Open1.08D1 Closing1.05Amplitude10.46%
Mkt Cap5.00MTradable Cap3.57MTotal Shares4.46M
T/O25.22KT/O Rate0.73%Tradable Shares3.18M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
DRYBAR ARRIVES AT SHOPPERS DRUG MART AND PHARMAPRIX STORES ACROSS CANADA
CNW Group  ·  05-03
DRYBAR ARRIVES AT SHOPPERS DRUG MART AND PHARMAPRIX STORES ACROSS CANADA
Psychedelic drug developers could benefit from NIH funding for chronic pain
seekingalpha  ·  04-30
Psychedelic drug developers could benefit from NIH funding for chronic pain
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
PR Newswire  ·  03-19
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
GlobeNewswire  ·  03-14
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
GlobeNewswire  ·  03-12
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
EAGLE HILL EXPANDS HEALTHCARE FOOTPRINT WITH BUSINESS OPERATIONS, OPTIMIZATION, AND MODERNIZATION BPA FOR U.S. FOOD AND DRUG ADMINISTRATION
StreetInsider  ·  03-08
EAGLE HILL EXPANDS HEALTHCARE FOOTPRINT WITH BUSINESS OPERATIONS, OPTIMIZATION, AND MODERNIZATION BPA FOR U.S. FOOD AND DRUG ADMINISTRATION
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
seekingalpha  ·  03-08
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
PR Newswire  ·  02-21
U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME
StreetInsider  ·  02-20
HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME
Psychedelic stocks gain after FDA priority review for MDMA therapy
seekingalpha  ·  02-13
Psychedelic stocks gain after FDA priority review for MDMA therapy
OMNIQ RECEIVES $5.0M IN PURCHASE ORDERS FOR THE SUPPLY OF HARDWARE, SOFTWARE AND SERVICES FOR ONE OF THE LARGEST US BASED FOOD AND DRUG CHAINS.
GlobeNewswire  ·  01-24
OMNIQ RECEIVES $5.0M IN PURCHASE ORDERS FOR THE SUPPLY OF HARDWARE, SOFTWARE AND SERVICES FOR ONE OF THE LARGEST US BASED FOOD AND DRUG CHAINS.
BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY
PR Newswire  ·  2023-12-20
BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY
TEAMSTERS APPLAUD FAA RULE ON DRUG TESTING FOR TECHNICIANS AT FOREIGN REPAIR STATIONS
StreetInsider  ·  2023-12-08
TEAMSTERS APPLAUD FAA RULE ON DRUG TESTING FOR TECHNICIANS AT FOREIGN REPAIR STATIONS
Press Release: Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management
Dow Jones  ·  2023-12-07
Press Release: Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management
EH, RX and VFS are among pre market gainers
seekingalpha  ·  2023-11-22
EH, RX and VFS are among pre market gainers

Introduction

Company Name.
Bright Minds Biosciences Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.
Issue price:
--